Further, at 2 months follow-up, IL-10 and TNF-alpha exhibited a decreased trend in helminth negative TB that was more pronounced and significant in TB patients infected with S. mansoni, indicating that anti-helminthic therapy could be considered during TB treatment in areas where helminths are common for the better control of disease progression and enhanced resolution of inflammation. Here, TNF is linked to tuberculosis.